ES2065954T3 - Derivados de pirrolo(1,4)benzodiazepina. - Google Patents
Derivados de pirrolo(1,4)benzodiazepina.Info
- Publication number
- ES2065954T3 ES2065954T3 ES89114483T ES89114483T ES2065954T3 ES 2065954 T3 ES2065954 T3 ES 2065954T3 ES 89114483 T ES89114483 T ES 89114483T ES 89114483 T ES89114483 T ES 89114483T ES 2065954 T3 ES2065954 T3 ES 2065954T3
- Authority
- ES
- Spain
- Prior art keywords
- benzodiazepina
- pirrolo
- derivatives
- chem
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UN COMPUESTO DE FORMULA (I), DONDE Y ES UN GRUPO DE FORMULA (A) O (B), R ES HIDROGENO, ALQUILO C1-C5, ALCANOILO C1-C5 O FENILALQUILO C7-C9, Y X ES HIDROGENO, ALCOXI C1-C5 O HALOGENO, QUE ES UTIL PARA EL TRATAMIENTO DE DEMENCIA SENIL, PSICONEUROSIS Y/O AMNESIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63196354A JP2660201B2 (ja) | 1988-08-05 | 1988-08-05 | 新規ピロロ[1,4]ベンゾジアゼピン誘導体および老人性痴呆薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2065954T3 true ES2065954T3 (es) | 1995-03-01 |
Family
ID=16356444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89114483T Expired - Lifetime ES2065954T3 (es) | 1988-08-05 | 1989-08-04 | Derivados de pirrolo(1,4)benzodiazepina. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4923984A (es) |
EP (1) | EP0353778B1 (es) |
JP (1) | JP2660201B2 (es) |
AT (1) | ATE113596T1 (es) |
DE (1) | DE68919148T2 (es) |
ES (1) | ES2065954T3 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011239525B2 (en) | 2010-04-15 | 2015-04-09 | Medimmune Limited | Pyrrolobenzodiazepines used to treat proliferative diseases |
EA024118B1 (ru) | 2010-04-15 | 2016-08-31 | Сиэтл Дженетикс, Инк. | Конъюгаты пирролбензодиазепина направленного действия |
AU2012311505B2 (en) | 2011-09-20 | 2016-09-29 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
EP3309162A1 (en) | 2011-10-14 | 2018-04-18 | Seattle Genetics, Inc. | Targeted conjugates of pyrrolobenzodiazepines |
CA2850373C (en) | 2011-10-14 | 2019-07-16 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
EP2751111B1 (en) | 2011-10-14 | 2017-04-26 | MedImmune Limited | Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases |
EA027386B1 (ru) | 2011-10-14 | 2017-07-31 | Медимьюн Лимитед | Пирролобензодиазепины |
SI2906296T1 (en) | 2012-10-12 | 2018-06-29 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
PT2839860T (pt) | 2012-10-12 | 2019-07-29 | Medimmune Ltd | Pirrolobenzodiazepinas e conjugados das mesmas |
ES2660029T3 (es) | 2012-10-12 | 2018-03-20 | Medimmune Limited | Conjugados de anticuerpo-pirrolobenzodiazepinas |
CA2885305C (en) | 2012-10-12 | 2019-11-12 | Spirogen Sarl | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
HUE035694T2 (en) | 2012-10-12 | 2018-05-28 | Adc Therapeutics Sa | Pirrolobenzodiazepine anti-CD22 antibody conjugates |
ES2703151T3 (es) | 2012-10-12 | 2019-03-07 | Adc Therapeutics Sa | Conjugados de anticuerpos de pirrolobenzodiazepinas |
EP2906250B1 (en) | 2012-10-12 | 2018-05-30 | ADC Therapeutics SA | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
NZ707486A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
TR201902494T4 (tr) | 2012-10-12 | 2019-03-21 | Medimmune Ltd | Pirrolobenzodiazepinler ve onların konjugatları. |
GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
EP3054985B1 (en) | 2013-10-11 | 2018-12-26 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
AU2015352545B2 (en) | 2014-11-25 | 2020-10-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
RS61795B1 (sr) | 2017-02-08 | 2021-06-30 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin antitela |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
WO2018192944A1 (en) | 2017-04-18 | 2018-10-25 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
EP3612234B1 (en) | 2017-04-20 | 2024-03-13 | ADC Therapeutics SA | Combination therapy with an anti-axl antibody-drug conjugate |
MX2019015042A (es) | 2017-06-14 | 2020-08-06 | Adc Therapeutics Sa | Regimen de dosificacion. |
AU2018316532B2 (en) | 2017-08-18 | 2022-11-24 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
CN114763356B (zh) * | 2021-01-11 | 2023-06-20 | 沈阳药科大学 | 吡咯并苯并二氮杂䓬类化合物及其制备方法和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
US3506647A (en) * | 1967-04-14 | 1970-04-14 | Sandoz Ag | Isoindolo(2,1-d)(1,4)benzodiazepin-6,9(7h,13bh)diones |
JPS4925277A (es) * | 1972-07-01 | 1974-03-06 | ||
JPS4949995A (es) * | 1972-09-22 | 1974-05-15 | ||
IT1045043B (it) * | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
US4369138A (en) * | 1980-07-15 | 1983-01-18 | Immuno Nuclear Corporation | Parathyroid radioimmunoassay |
-
1988
- 1988-08-05 JP JP63196354A patent/JP2660201B2/ja not_active Expired - Lifetime
-
1989
- 1989-07-31 US US07/386,946 patent/US4923984A/en not_active Expired - Fee Related
- 1989-08-04 EP EP89114483A patent/EP0353778B1/en not_active Expired - Lifetime
- 1989-08-04 ES ES89114483T patent/ES2065954T3/es not_active Expired - Lifetime
- 1989-08-04 DE DE68919148T patent/DE68919148T2/de not_active Expired - Fee Related
- 1989-08-04 AT AT89114483T patent/ATE113596T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH0245487A (ja) | 1990-02-15 |
JP2660201B2 (ja) | 1997-10-08 |
EP0353778A2 (en) | 1990-02-07 |
DE68919148T2 (de) | 1995-03-09 |
EP0353778A3 (en) | 1991-07-17 |
US4923984A (en) | 1990-05-08 |
EP0353778B1 (en) | 1994-11-02 |
DE68919148D1 (de) | 1994-12-08 |
ATE113596T1 (de) | 1994-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2065954T3 (es) | Derivados de pirrolo(1,4)benzodiazepina. | |
FI95469C (fi) | Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi | |
ES2097583T3 (es) | Procedimiento de preparacion de derivados de alcoxiiminoacetamida y un intermediario de este procedimiento. | |
HU906029D0 (en) | Process for the preparation of pleuromuthylyne derivatives | |
HUT49860A (en) | Process for producing benzamide-type protease inhibitors | |
ES2075850T3 (es) | Derivados de beta-lactama. | |
DK594486D0 (da) | Heterocykliske forbindelser | |
HUT45984A (en) | Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts | |
HU906360D0 (en) | Process for producing quinoline derivatives and pharmaceutical preparatives containing such compounds | |
HUT42092A (en) | Process for production of derivatives of 3-vinil and 3-ethinil-beta-carbolin and medical preparatives containing thereof | |
GR3030718T3 (en) | Novel prostaglandin analogue. | |
DK0382660T3 (da) | Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer | |
EP0407621A4 (en) | Benzothiazole derivatives | |
DK0541322T3 (da) | 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet | |
YU48634B (sh) | Postupak za dobijanje 6-(supstituisanih aminopropionil) derivata forskolina i jedinjenja koja se dobijaju ovim postupkom | |
NO903514D0 (no) | Imidazolderivat og fremgangsmaate til dets fremstilling. | |
GB8830226D0 (en) | Novel compounds | |
MY106898A (en) | Aromatic compounds, their production processes and their compositions for the control of insect pests | |
DE3879058D1 (de) | 4-piperidincarboxamid-derivate. | |
ATE189813T1 (de) | Prostaglandin-i-analoga | |
ATE90101T1 (de) | Verfahren zur herstellung von makrolid-derivaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 353778 Country of ref document: ES |